Lantern Pharma Inc. (LTRN): Price and Financial Metrics

Lantern Pharma Inc. (LTRN): $3.67

0.15 (+4.26%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add LTRN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#158 of 304

in industry

LTRN Price/Volume Stats

Current price $3.67 52-week high $7.21
Prev. close $3.52 52-week low $2.55
Day low $3.46 Volume 2,058
Day high $3.67 Avg. volume 72,100
50-day MA $3.61 Dividend yield N/A
200-day MA $3.81 Market Cap 39.58M

LTRN Stock Price Chart Interactive Chart >


Lantern Pharma Inc. (LTRN) Company Bio


Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.


LTRN Latest News Stream


Event/Time News Detail
Loading, please wait...

LTRN Latest Social Stream


Loading social stream, please wait...

View Full LTRN Social Stream

LTRN Price Returns

1-mo 10.88%
3-mo -25.86%
6-mo 10.88%
1-year -31.91%
3-year -36.40%
5-year N/A
YTD 15.05%
2024 -25.47%
2023 -29.14%
2022 -24.31%
2021 -58.55%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!